China Pharma Holdings, Inc. - stock earnings
CPHI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -777600 USD | 1.8 million USD |
| 2023Q2 | -593029 USD | 1.1 million USD |
| 2023Q1 | -2.0 million USD | 2.0 million USD |
| 2022Q4 | -1.3 million USD | 2.9 million USD |
| 2022Q3 | -2.3 million USD | 2.0 million USD |
| 2022Q2 | -2.5 million USD | 1.6 million USD |
| 2022Q1 | -2.7 million USD | 1.6 million USD |
| 2021Q4 | -3.1 million USD | 2.9 million USD |
| 2021Q3 | -826669 USD | 2.0 million USD |
| 2021Q2 | -824761 USD | 2.4 million USD |
| 2021Q1 | -767327 USD | 2.4 million USD |
| 2020Q4 | -1.2 million USD | 2.9 million USD |
| 2020Q3 | -1.0 million USD | 2.4 million USD |
| 2020Q2 | 13053 USD | 3.8 million USD |
| 2020Q1 | -660897 USD | 1.8 million USD |
| 2019Q4 | -18.7 million USD | 3.0 million USD |
| 2019Q3 | -700954 USD | 2.4 million USD |
| 2019Q2 | -838103 USD | 2.6 million USD |
| 2019Q1 | -417731 USD | 2.9 million USD |
| 2018Q4 | -7.6 million USD | 3.2 million USD |
| 2018Q3 | -1.9 million USD | 2.3 million USD |
| 2018Q2 | -1.0 million USD | 3.2 million USD |
| 2018Q1 | -13.8 million USD | 3.8 million USD |
| 2017Q4 | -13.8 million USD | 3.8 million USD |
| 2017Q3 | -2.2 million USD | 3.2 million USD |
| 2017Q2 | -2.3 million USD | 2.9 million USD |
| 2017Q1 | -966898 USD | 3.3 million USD |
| 2016Q4 | -3.4 million USD | 5.3 million USD |
| 2016Q3 | -1.7 million USD | 3.1 million USD |
| 2016Q2 | -2.5 million USD | 3.5 million USD |
| 2016Q1 | -1.6 million USD | 3.6 million USD |
| 2015Q4 | 832510 USD | 4.5 million USD |
| 2015Q3 | -4.1 million USD | 4.5 million USD |
| 2015Q2 | -4.1 million USD | 5.7 million USD |
| 2015Q1 | -8.0 million USD | 5.7 million USD |
| 2014Q4 | -8.7 million USD | 3.3 million USD |
| 2014Q3 | -6.3 million USD | 5.6 million USD |
| 2014Q2 | -8.6 million USD | 6.1 million USD |
| 2014Q1 | -2.4 million USD | 7.1 million USD |
| 2013Q4 | -10.4 million USD | 8.4 million USD |
| 2013Q3 | -2.3 million USD | 8.1 million USD |
| 2013Q2 | -4.5 million USD | 8.0 million USD |
| 2013Q1 | -2.8 million USD | 8.2 million USD |
| 2012Q4 | -1.2 million USD | 11.6 million USD |
| 2012Q3 | 1.3 million USD | 12.2 million USD |
| 2012Q2 | 1.8 million USD | 14.6 million USD |
| 2012Q1 | 2.8 million USD | 16.1 million USD |
| 2011Q4 | 5.8 million USD | 22.5 million USD |
| 2011Q3 | 3.3 million USD | 21.0 million USD |
| 2011Q2 | 5.1 million USD | 19.6 million USD |
| 2011Q1 | 5.1 million USD | 18.1 million USD |
| 2010Q4 | 8.4 million USD | 24.0 million USD |
| 2010Q3 | 5.5 million USD | 18.7 million USD |
| 2010Q2 | 5.3 million USD | 16.6 million USD |
| 2010Q1 | 4.3 million USD | 15.1 million USD |
| 2009Q4 | 5.1 million USD | 19.6 million USD |
| 2009Q3 | 7.2 million USD | 15.5 million USD |
| 2009Q2 | 4.3 million USD | 13.6 million USD |
| 2009Q1 | 3.7 million USD | 13.0 million USD |
| 2008Q4 | 5.4 million USD | 15.4 million USD |
| 2008Q3 | 4.3 million USD | 12.6 million USD |
| 2008Q2 | 4.0 million USD | 11.3 million USD |
| 2008Q1 | 4.2 million USD | 11.7 million USD |
| 2007Q4 | 4.0 million USD | 9.1 million USD |
| 2007Q3 | 3.1 million USD | 8.3 million USD |
| 2007Q2 | 3.3 million USD | 8.6 million USD |
| 2007Q1 | 2.4 million USD | 7.2 million USD |
| 2006Q4 | 3.5 million USD | 8.1 million USD |
| 2006Q3 | 1.7 million USD | 5.0 million USD |
| 2006Q2 | 1.8 million USD | 4.0 million USD |
| 2006Q1 | 1.6 million USD | 4.7 million USD |
| 2005Q4 | 3.2 million USD | 5.6 million USD |
| 2005Q3 | 510410 USD | 2.6 million USD |
| 2005Q2 | -1.8 million USD | ? USD |
| 2005Q1 | -35678 USD | ? USD |
| 2004Q4 | -17357 USD | ? USD |
| 2004Q3 | -98172 USD | -2500 USD |
| 2004Q2 | -98172 USD | -2500 USD |
| 2004Q1 | 3502 USD | 18458 USD |
| 2003Q4 | -563 USD | 2500 USD |
| 2003Q3 | -40643 USD | 14725 USD |
| 2003Q2 | -40643 USD | 14725 USD |
| 2003Q1 | -81579 USD | 5079 USD |
| 2002Q4 | -103598 USD | 3850 USD |
| 2002Q3 | -474449 USD | 1370 USD |
| 2002Q2 | -474449 USD | 1370 USD |
| 2002Q1 | -359405 USD | 8624 USD |
| 2001Q4 | -99403 USD | 24614 USD |
| 2001Q3 | -170876 USD | 2882 USD |
CPHI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -3.1 million USD | 7.8 million USD |
| 2022 | -10.2 million USD | 8.1 million USD |
| 2021 | -3.9 million USD | 9.6 million USD |
| 2020 | -3.2 million USD | 10.9 million USD |
| 2019 | -21.0 million USD | 10.9 million USD |
| 2018 | -10.8 million USD | 12.3 million USD |
| 2017 | -19.3 million USD | 13.2 million USD |
| 2016 | -9.2 million USD | 15.6 million USD |
| 2015 | -15.4 million USD | 20.4 million USD |
| 2014 | -26.0 million USD | 22.1 million USD |
| 2013 | -20.0 million USD | 32.8 million USD |
| 2012 | 4.6 million USD | 54.5 million USD |
| 2011 | 19.3 million USD | 81.2 million USD |
| 2010 | 23.4 million USD | 74.4 million USD |
| 2009 | 20.2 million USD | 61.7 million USD |
| 2008 | 17.8 million USD | 51.0 million USD |
| 2007 | 12.8 million USD | 33.2 million USD |
| 2006 | 8.6 million USD | 21.8 million USD |
| 2005 | 3.8 million USD | 8.7 million USD |
| 2004 | -504292 USD | 23275 USD |
| 2003 | -226365 USD | 110079 USD |
| 2002 | -1.1 million USD | 37490 USD |
| 2001 | -1.1 million USD | 37490 USD |
CPHI
Price: $0.32
52 week price:
Earnings Per Share: -1.90 USD
P/E Ratio: -0.25
Exchange: ASE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 955400
Market Capitalization: 3.8 million